FSAG
NVO

Financial Solutions Advisory Group’s Novo Nordisk NVO Stock Holding History

Financial Solutions Advisory Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$612K Sell
12,526
-4,651
-27% -$200K 0.08% 97
2026
Q1 		$631K Buy
+17,177
New +$814K 0.09% 89

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Financial Solutions Advisory Group's NVO Position: Q2 2026 in Review

Financial Solutions Advisory Group reduced its Novo Nordisk (NVO) stake by 27% in Q2 2026, selling an estimated $200K and leaving 12,526 shares worth $612K. The position accounts for 0.08% of the portfolio, ranked #97.

Financial Solutions Advisory Group first reported a position in NVO in Q1 2026 and has held it in 2 quarters since. The position peaked at $631K in Q1 2026. 334 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Financial Solutions Advisory Group held 12,526 shares of Novo Nordisk worth $612K as of Q2 2026.
  • Financial Solutions Advisory Group sold 4,651 Novo Nordisk shares in Q2 2026, an estimated $200K.
  • Novo Nordisk made up 0.08% of Financial Solutions Advisory Group's portfolio in Q2 2026, its #97 holding.
  • Financial Solutions Advisory Group first reported a position in Novo Nordisk in Q1 2026 and has held it in 2 quarters since.
  • Financial Solutions Advisory Group's Novo Nordisk position peaked at $631K in Q1 2026.
  • 334 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Financial Solutions Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.